Topical PDRN Skincare: What the Research Shows vs Injectables

Last updated: June 2026

Quick Answer

• PDRN is salmon-DNA fragments that switch on the skin's A2A repair receptor.
• Strong human evidence exists for injected PDRN, not topical serums.
• PDRN is large, so topical penetration is the open scientific question.
• Topical PDRN serums are low-risk but mostly unproven for deep repair.

Medical and patch-test disclaimer: This article reviews published research for educational purposes only. It is not medical advice and does not replace a board-certified dermatologist. PDRN injectables are regulated biologics, and availability varies by country. Before trying any new serum, patch-test a small area on your inner forearm for 48 hours to check for irritation or allergy. Talk to a licensed provider before booking injections or starting actives if you are pregnant, breastfeeding, or have a salmon or fish allergy.

Affiliate disclosure: The Exosome Edit may earn a small commission if you buy through links here, at no extra cost to you.

---

PDRN went from a clinic secret to a viral serum ingredient in about two years. Search volume for "pdrn serum" now tops 18,000 a month. But the marketing is racing ahead of the science.

Here's the honest version. The molecule has real, decades-deep research behind it. Almost all of that research used injections or wound dressings, not a serum you smooth on at home. So the question isn't "does PDRN work?" It's "does PDRN work the way your serum bottle claims?"

This review walks through the mechanism, the clinical evidence, and the topical-penetration problem. We'll keep the hype out and the citations in.

A quick note on terms. Online, "PDRN," "PN," "polynucleotide," and brand names like Rejuran get used almost interchangeably. They're related but not identical, and the differences matter once you start comparing products.

Does topical PDRN actually work, or do you need injections?

The strongest evidence for PDRN comes from injections and wound dressings, not serums. Injected PDRN delivers the molecule straight into the dermis where fibroblasts live, which is exactly where it needs to be. A topical serum has to cross the stratum corneum first, and PDRN is a large molecule that does not cross easily.

That doesn't make topical PDRN useless. It likely offers surface-level hydration and soothing. But for collagen rebuilding and scar remodeling, the published proof sits almost entirely on the injectable side (Squadrito et al., 2017).

So treat a PDRN serum as a gentle support step, not a needle-free replacement for Rejuran. The evidence gap is real, and your expectations should match it.

What is PDRN and how does it work? (mechanism — A2A receptor, salvage pathway)

PDRN stands for polydeoxyribonucleotide. It's a mix of short DNA fragments, usually 50 to 1,500 kilodaltons, purified from salmon or trout sperm cells. The fragments are highly similar to human DNA, which is why the body recognizes them instead of attacking them.

PDRN works through two main routes. First, it activates the adenosine A2A receptor on fibroblasts and immune cells. That receptor switch raises cyclic AMP, calms inflammation, and tells fibroblasts to make more collagen and new blood vessels (Squadrito et al., 2017).

Second, PDRN feeds the "salvage pathway." When cells break the fragments down, they reuse the freed nucleotides as cheap building blocks for new DNA. Stressed or healing cells love this shortcut because making nucleotides from scratch is costly (Colangelo et al., 2020).

In lab studies, this combination pushed human skin fibroblasts to grow faster, and blocking the A2 receptor cancelled the effect (Thellung et al., 1999). That's the cellular engine behind every PDRN claim you'll read.

What does the clinical evidence show for PDRN? (mostly injectable — Rejuran)

Most human and animal evidence tests PDRN given by injection or as a wound treatment, and the results are consistent. A systematic review of the wound-healing literature found that PDRN sped up healing and tissue regeneration across multiple studies, mainly through A2A activation (Colangelo et al., 2020).

A 2021 review of impaired skin wounds reached the same conclusion. PDRN promoted cell migration, new blood vessels, and lower inflammation in diabetic, burn, and ischemic wound models, in vitro, in animals, and in clinical use (Galeano et al., 2021).

In aesthetics, the best-known injectable is Rejuran, a polynucleotide product from Korea's Pharma Research. Clinics inject it to improve skin elasticity, hydration, and fine lines. Be aware: a frequently cited 2014 phase III "crow's feet" trial on this product was later retracted, so it should not be used as proof of efficacy.

That retraction is worth pausing on. It doesn't mean PDRN fails; it means the aesthetic evidence base is younger and shakier than the wound-healing one, where the molecule has been studied for decades. When a brand cites "clinical proof," ask whether the study tested wounds or wrinkles, and whether it used injection or a serum.

The cleaner takeaway is that newer reviews still describe consistent skin-quality gains from injected polynucleotides while calling for larger, standardized trials (Kim, 2025). The direction is promising. The high-quality, head-to-head proof is still thin.

PDRN study snapshot

This table shows where the evidence actually lives. Notice how the route is almost always injection or wound dressing, not a leave-on serum.

Study (author, year)	Route tested	Model	Key outcome
Thellung et al., 1999	In-vitro exposure	Human skin fibroblasts	Faster fibroblast growth; blocked by A2 antagonist
Squadrito et al., 2017	Mixed (mostly injectable)	Review of in vitro, animal, clinical	A2A receptor is the core mechanism; anti-inflammatory + pro-repair
Colangelo et al., 2020	Injection / topical wound	Systematic review	Faster wound healing and tissue regeneration
Galeano et al., 2021	Local + systemic	Diabetic, burn, ischemic wounds	More angiogenesis, less inflammation, better healing
Yu & Lee, 2017	Injection	Rat fractional-laser wounds	Faster healing, more granulation tissue and vessels
Kim, 2025	Injection (PN vs PDRN)	Dermatology review	PDRN drives A2A repair; PN adds structure and hydration

Can PDRN penetrate skin topically? (molecular-size reality check)

This is the crux of the topical debate. The stratum corneum, your outer skin layer, generally blocks molecules larger than about 500 daltons from passing through intact. PDRN fragments run from roughly 50,000 to 1,500,000 daltons.

That's hundreds to thousands of times above the usual penetration ceiling. Without help, most PDRN in a serum likely sits on the surface rather than reaching the fibroblasts in the dermis. This is the same size hurdle that limits many large skincare actives.

That's why injectables and microneedling exist. They bypass the barrier and place PDRN where it can act (Yu & Lee, 2017). It's also why topical-PDRN-specific clinical trials are scarce. We have strong mechanism data and strong injectable data, but little controlled proof that a leave-on serum delivers a meaningful dermal dose.

Some brands add penetration enhancers, low-molecular-weight fragments, or liposomes to improve uptake. These are reasonable ideas. They are not yet backed by the kind of published, peer-reviewed human trials that injectable PDRN can point to.

PDRN vs exosomes vs PRP — how do they compare?

All three are "regenerative" skincare tools, but they work differently. PDRN is a defined chemical: salmon DNA fragments that trigger one main receptor pathway. That makes it consistent and easy to standardize batch to batch.

Exosomes are tiny vesicles, 30 to 150 nanometers, that carry a mixed cargo of proteins, growth factors, and RNA between cells. PRP, platelet-rich plasma, is your own blood spun down to concentrate platelets and their growth factors. Both are more complex and more variable than PDRN.

For a deeper side-by-side, see our salmon DNA PDRN vs exosomes skin booster showdown and our PRP vs exosomes comparison. The short version is below.

Attribute comparison

Attribute	PDRN	Exosomes	PRP
What it is	Salmon/trout DNA fragments	Cell-derived vesicles (30–150 nm)	Concentrated own-blood platelets
Main mechanism	A2A receptor + salvage pathway	Multi-signal cargo delivery	Growth-factor release
Source	Fish (consistent, off-the-shelf)	Donor or stem-cell lines	Your own blood (autologous)
Standardization	High (defined molecule)	Low–moderate (variable cargo)	Low (varies per patient)
Best-evidenced route	Injection / wound dressing	Mostly post-procedure topical	Injection
Topical penetration	Poor (large molecule)	Debated (small but still hindered)	Not designed for topical
Allergy note	Avoid if fish-allergic	Generally low	Minimal (autologous)

If you want the cell-signaling detail on vesicles, our explainer on how exosomes actually work breaks it down. The takeaway: PDRN is the most chemically defined of the three, which is a real advantage for consistency.

There's a practical angle here too. Because PDRN is a single defined molecule from fish, batches are easier to standardize and store than exosomes (whose cargo can drift between lots) or PRP (which depends on each patient's blood). PDRN trades some biological richness for that predictability, which is part of why it scaled into off-the-shelf serums so fast.

What PDRN concentration is in serums, and does it matter?

Most topical PDRN serums list concentrations between roughly 0.5% and 2%, though many brands don't disclose an exact figure. Higher numbers look impressive on a label. But concentration only matters if the molecule actually reaches the dermis.

That's the catch. A 2% serum that mostly sits on the skin surface may do less deep work than a lower-dose injectable delivered into the tissue. With PDRN, delivery beats concentration. The molecular-size barrier doesn't care how much you applied if little of it crosses (Kim, 2025).

There's also a naming gray zone. Some products labeled "PN" use longer polynucleotide chains that behave more like a hydrating, film-forming agent than a true A2A activator. A recent review proposed a 1,500 kDa cutoff to separate PDRN from PN, which tells you the field is still standardizing its own terms (Marques et al., 2025).

So read past the percentage. Look for whether the brand explains its delivery system and fragment size, not just a big number on the front.

Is topical PDRN worth it? (honest take)

Here's my honest read. Topical PDRN is low-risk, gentle, and may help with surface hydration and post-procedure soothing. As an add-on to a solid routine, it's reasonable. As a standalone fix for wrinkles or scars, the evidence isn't there yet.

If your goal is real collagen remodeling, the published proof points to in-office injectables or microneedling-assisted delivery, not a leave-on serum. A serum can't yet match what a needle delivers, simply because of the size barrier. That's not marketing skepticism. It's basic skin biology.

If you still want to try a topical, pair it with a microneedling protocol under professional guidance, or use it after a clinic treatment when your barrier is briefly more permeable. And keep your other proven actives, retinoids, vitamin C, sunscreen, doing the heavy lifting.

One more honest caveat. Much of the topical-PDRN marketing borrows credibility from the injectable and wound-healing studies, then quietly implies the serum does the same thing. It might, but we don't have the controlled human trials to say so yet. Until those exist, judge a PDRN serum on how it feels and soothes, not on a collagen claim it hasn't earned.

For a routine-building angle, our guide on building an exosome-plus-tretinoin routine shows how to layer a regenerative step with a proven retinoid. The same logic applies to PDRN: support player, not headliner.

Frequently Asked Questions

Is topical PDRN as effective as Rejuran injections? No, not based on current published evidence. Rejuran and other injectables deliver PDRN directly into the dermis, while a serum must cross a barrier that blocks large molecules. The deep-repair proof sits on the injectable side.

Can PDRN serums penetrate the skin? Probably not very well on their own. PDRN molecules are far larger than the roughly 500-dalton limit for easy skin penetration. Some serums add enhancers or smaller fragments, but those approaches lack strong published human trials.

Is PDRN safe if I have a salmon or fish allergy? You should avoid it or consult an allergist first. PDRN is derived from salmon or trout cells, so a fish allergy is a real concern. Always patch-test any new product and stop if you notice redness, itching, or swelling.

What's the difference between PDRN and PN (polynucleotide)? They overlap, but PDRN refers to shorter DNA fragments that activate the A2A repair receptor, while PN refers to longer chains that act more like a hydrating, structural gel. A 2025 review proposed a 1,500 kDa cutoff to tell them apart (Marques et al., 2025).

Does a higher PDRN percentage in a serum mean better results? Not necessarily. Concentration only helps if the molecule actually reaches the dermis, and PDRN struggles to cross the skin barrier. Delivery method matters more than the percentage printed on the label.

Related Reading

• Salmon DNA PDRN vs Exosomes: The 2026 Skin Booster Showdown
• Salmon DNA vs Stem Cell Exosomes (2026)
• PRP vs Exosomes: Which Regenerative Treatment Wins?

-- The Exosome Edit Team